Generate Bio private stock trade

Generate Bio

Legal NameGenerate Biomedicines, Inc.
HeadquartersLandsdowne, PA
SectorBioTech

Generate Biomedicines is a biotechnology company specializing in the development of novel therapeutics using AI-driven drug discovery approaches. The company focuses on leveraging artificial intelligence, machine learning, and genomics to identify and optimize therapeutic candidates for challenging diseases. Generate Biomedicines aims to accelerate the drug discovery process by integrating computational biology with experimental validation, aiming to bring transformative treatments to patients faster. The company's research and development efforts center on innovative approaches to target diseases with high unmet medical needs, positioning Generate Biomedicines at the forefront of biopharmaceutical innovation.

Learn more about Generate Bio IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Generate Bio, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Generate Bio, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.